臨床検査64巻3号

2020年03月発行

今月の特集1 Clostridioides difficile感染症—近年の話題

Clostridioides difficile感染症のサーベイランスと臨床疫学

著者： 高松茜¹ 本田仁¹

所属機関： ¹東京都立多摩総合医療センター感染症科

ページ範囲：P.220 - P.225

Point

●Clostridioides difficile感染症（CDI）は，医療関連感染（HAIもしくはHCAI）の1つであり，院内下痢症の主要な原因疾患である．

●CDIのリスク因子として過去の抗菌薬使用が最も重要であり，抗菌薬適正使用の指標の1つとなりうる．

●日本国内では，国家的なCDIのサーベイランスは存在しないが，感染対策上のインパクトの大きい感染症であり，各医療施設での持続的なモニタリングと定期的な報告が期待される．

参考文献

1）Kwon JH, Olsen MA, Dubberke ER：The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am　29：123-134，2015

2）Honda H, Kato H, Olsen MA, et al：Risk factors for Clostridioides difficile infection in hospitalized patients and associated mortality in Japan: a multi-centre prospective cohort study. J Hosp Infect, 2019, in press

3）McDonald LC, Coignard B, Dubberke E, et al：Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol　28：140-145，2007

4）Lessa FC, Mu Y, Bamberg WM, et al：Burden of Clostridium difficile infection in the United States. N Engl J Med　372：825-834，2015

5）Dubberke ER, Butler AM, Yokoe DS, et al：Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol　31：1030-1037，2010

6）Centers for Disease Control and Prevention (CDC)：Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep　61：157-162，2012

7）Centers for Disease Control and Prevention (CDC)：Antibiotic Resistance Threats in the United States, 2013（https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf）（最終アクセス：2019年9月24日）

8）Zarb P, Coignard B, Griskeviciene J, et al：The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill　17，2012

9）Suetens C, Latour K, Kärki T, et al：Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill　23，2018

10）European Centre for Disease Prevention and Control (ECDC)：Healthcare-associated infections: Clostridium difficile infections. In: ECDC. Annual Epidemiological Report for 2016（https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2016-C-difficile_0.pdf）（最終アクセス：2019年9月24日）

11）Kotila SM, Mentula S, Ollgren J, et al：Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008-2013(1). Emerg Infect Dis　22：1747-1753，2016

12）Public Health England：Clostridium difficile infection: mandatory surveillance 2017/18 Summary of the Mandatory Surveillance Annual Epidemiological Commentary 2017/18（https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/724368/CDI_summary_2018.pdf）（最終アクセス：2019年9月24日）

13）National Services Scotland：Clostridioides difficile Infection. Healthcare associated infection: Annual report 2018（https://hpspubsrepo.blob.core.windows.net/hps-website/nss/2776/documents/5_CDI_infographics2019.pdf）（最終アクセス：2019年9月24日）

14）Kola A, Wiuff C, Akerlund T, et al：Survey of Clostridium difficile infection surveillance systems in Europe, 2011. Euro Surveill　21，2016

15）Collins DA, Hawkey PM, Riley TV：Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control　2：21，2013

16）Borren NZ, Ghadermarzi S, Hutfless S, et al：The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact. PLoS One　12：e0176797，2017

17）McDonald LC, Gerding DN, Johnson S, et al：Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis　66：987-994，2018

18）Kato H, Senoh M, Honda H, et al：Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study. Anaerobe, 2019, in press

19）Riley TV, Kimura T：The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review. Infect Dis Ther　7：39-70，2018

20）Davies KA, Longshaw CM, Davis GL, et al：Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis　14：1208-1219，2014